Overview

Peto R Lopez AD Boreham J Thun M Heath C Jr. Mortality from smoking in developed countries 1950-2000. Oxford: Oxford University Press; 1994.

Rose G. The strategy of preventive medicine. Oxford: Oxford Medical Publications; 1992.

McCully KS. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969; 56:111–128.

Wilcken DEL Wilcken B. The pathogenesis of coronary artery disease: A possible role for methionine metabolism. J Clin Invest 1976; 57:1079–1082.

Wilcken DE Wilcken B. The natural history of vascular disease in homocystinuria and the effects of treatment. J Inherit Metab Dis 1997; 20:295–300.

Scott JM Weir DG. The methyl folate trap. A physiological response in man to prevent methyl group deficiency in Kwashiorkor (methionine deficiency) and an explanation for folic-acid induced exacerbation of subacute combined degeneration of the cord. Lancet 1981; ii:337–340.

Domagala∗ B Undas A Jankowski M Libura M Szczeklik A. Thrombin generation in hyperhomocysteinemia before and after treatment with folic acid and vitamin B-12. Thromb Haemost 1997; 530:269.

Clarke R Daly L Robinson K Naughten E Cahalane S Fowler B Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 1991; 324:1149–1155.

Ueland PM Refsum HM Stabler SP Malinow MR Andersson A Allen RH. Total homocysteine in plasma or serum. Methods or clinical applications. Clin Chem 1993; 39:1764–1779.

Boushey CJ Beresford SA Omen∗ GS Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995; 274:1049–1057.

Arnesen E Refsum H Bonaa KH Ueland PM Forde OH Nordrehaug JE Serum total homocysteine and coronary heart disease. Int J Epidemiol 1995; 24:704–709.

Alfthan G Pekkanen J Jauhiainen M Pitkaniemi J Karvonen M Tuomilehto J Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 1994; 106:9–19.

Evans RW Shaten BJ Hempel JD Cutler JA Kuller LH. Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial. Arterioscler Thromb Vasc Biol 1997; 17:1947–1953.

Perry I Refsum H Morris RW Ebrahim S Ueland PM Shaper AG. A prospective study of serum homocysteine concentration and risk of stroke in middle-aged men. Lancet 1995; 346:1395–1398.

Stein JH McBride PE. Hyperhomocysteinemia and atherosclerotic vascular disease: Pathophysiology, screening and treatment. Arch Intern Med 1998; 158:1301–1306.

Oakley GP. Eat right and take a multivitamin. N Engl J Med 1998; 338:1060–1061.

Omenn GS Beresford SAA Motulsky AG. Preventing coronary heart disease: B vitamins and homocysteine. Circulation 1998; 97:421–424.

Homocysteine Lowering Trialist's Collaboration. Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomised trials. BMJ 1998; 316:894–898.

Shipchandler MT Moore EG. Rapid, fully automated measurement of plasma homocystein(e)ine with the Abbott Imx Analyzer. Clin Chem 1995; 41:991–994.